NCT00870142View on ClinicalTrials.gov

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Healthy
Interventions
DRUG

AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose

A: Experimental Subjects received EMCURE PHARMACEUTICALS LTD. formulated products under fasting conditions

DRUG

Norvasc® 10 mg Tablets

B: Active comparator Subjects received Pfizer Labs Division of Pfizer Inc. formulated products under fasting conditions

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Saint-Laurent, Montreal

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00870142 - A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter